Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.

Poorly water-soluble drugs such as nifedipine (NIF) (approximately 20 microg/ml) offer challenging problems in drug formulation as poor solubility is generally associated to poor dissolution characteristics and thus to poor oral bioavailability. In order to enhance these characteristics, preparation of nifedipine nanoparticles has been achieved using high pressure homogenization. The homogenization procedure has first been optimized in regard to particle size and size distribution. Nanoparticles were characterized in terms of size, morphology and redispersion characteristics following water-removal. Saturation solubility and dissolution characteristics were investigated and compared to the un-milled commercial NIF to verify the theoretical hypothesis on the benefit of increased surface area. Crystalline state evaluation before and following particle size reduction was also conducted through differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) to denote eventual transformation to amorphous state during the homogenization process. Through this study, it has been shown that initial crystalline state is maintained following particle size reduction and that the dissolution characteristics of nifedipine nanoparticles were significantly increased in regards to the commercial product. The method being simple and easily scaled up, this approach should have a general applicability to many poorly water-soluble drug entities.

[1]  D. Grant,et al.  Solid-state characterization of nifedipine solid dispersions. , 2002, International journal of pharmaceutics.

[2]  Kunio Ito,et al.  A Nifedipine Coground Mixture with Sodium Deoxycholate. II. Dissolution Characteristics and Stability , 2001, Drug development and industrial pharmacy.

[3]  M. Sugimoto,et al.  Improvement of dissolution characteristics and bioavailability of poorly water-soluble drugs by novel cogrinding method using water-soluble polymer , 1998 .

[4]  M. Bayomi,et al.  Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state. , 2002, International journal of pharmaceutics.

[5]  Zheng Wang,et al.  Effect of 2-Hydroxypropyl-β-cyclodextrin on Crystallization and Polymorphic Transition of Nifedipine in Solid State , 1994, Pharmaceutical Research.

[6]  R. J. Hintz,et al.  The effect of particle size distribution on dissolution rate and oral absorption , 1989 .

[7]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[8]  J. Rogers,et al.  Characterization and dissolution behavior of nifedipine and phosphatidylcholine binary systems , 1996 .

[9]  Mitra Mosharraf,et al.  The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs , 1995 .

[10]  R. Müller,et al.  Nanosuspensions of poorly soluble drugs--reproducibility of small scale production. , 2000, International journal of pharmaceutics.

[11]  M. Otsuka,et al.  Evaluation of photostability of solid-state dimethyl 1,4-dihydro-2, 6-dimethyl-4-(2-nitro-phenyl)-3,5-pyridinedicarboxylate by using Fourier-transformed reflection-absorption infrared spectroscopy. , 1999, International journal of pharmaceutics.

[12]  Ž. Knez,et al.  Improvement of nifedipine dissolution characteristics using supercritical CO2 , 1997 .

[13]  M. Bele,et al.  Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method. , 2005, International journal of pharmaceutics.

[14]  G. Liversidge,et al.  Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs , 1995 .

[15]  A. Rajabi-Siahboomi,et al.  Investigation of the polymorphic transformations from glassy nifedipine , 2003 .

[16]  T. Cham,et al.  Effect of particle size on the available surface area of nifedipine from nifedipine-polyethylene glycol 6000 solid dispersions , 1996 .

[17]  T. P. Dasbach,et al.  A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose. , 2003, International journal of pharmaceutics.

[18]  Y. Ogawa,et al.  Improved oral absorption of a poorly water-soluble drug, HO-221, by wet-bead milling producing particles in submicron region. , 1993, Chemical & pharmaceutical bulletin.

[19]  R. Müller,et al.  Production and characterisation of highly concentrated nanosuspensions by high pressure homogenisation. , 2001, International journal of pharmaceutics.

[20]  Kevin C. Johnson,et al.  Dissolution Modeling: Factors Affecting the Dissolution Rates of Polydisperse Powders , 1993, Pharmaceutical Research.

[21]  K. Ohyama,et al.  Pharmacokinetics of a micronized, poorly water-soluble drug, HO-221, in experimental animals. , 1993, Biological & pharmaceutical bulletin.

[22]  P. Minghetti,et al.  Characterization of nifedipine solid dispersions. , 2002, International journal of pharmaceutics.

[23]  C. Remuñán-López,et al.  Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine , 1998 .